Signal Not Noise: What Mattered in Women’s Health Investing (Apr 14–19)

Women’s health insights through an investor lens. Because headlines fade. Signals shape strategy.

What if the real signal this week wasn’t another funding headline but how we measure credibility? From regulatory risk to clinical validation, a new bar is emerging. Startups aren’t just expected to build, they are expected to prove. The women's health market is trading on more than promises. It’s asking for evidence.